Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,TYROBP causal network in microglia WP3945,2.173693228336463e-09,7.95936754176611,158.7642162714607,"['CD84', 'RBM47', 'ITGB2', 'GIMAP2', 'RNASE6', 'TCIRG1', 'SLC1A5', 'TNFRSF1B', 'RUNX3', 'APBB1IP', 'LYL1', 'TYROBP', 'ELF4', 'HCLS1', 'CYTL1', 'IL13RA1', 'C1QC']",8.132674491822586e-07,0,0,17
2,Microglia Pathogen Phagocytosis Pathway WP3937,3.791456639544329e-09,10.460214030915576,202.82894286547662,"['C1QB', 'C1QA', 'FCER1G', 'SYK', 'NCF4', 'ITGB2', 'CYBB', 'CYBA', 'PIK3R6', 'HCK', 'TYROBP', 'FCGR1A', 'SIGLEC7', 'C1QC']",8.132674491822586e-07,0,0,14
3,"GPCRs, Class A Rhodopsin-like WP455",7.55001552606048e-09,4.09568534818106,76.59634509685445,"['CX3CR1', 'OXTR', 'GPR68', 'GPR65', 'OPRL1', 'ADRA1D', 'MCHR1', 'CYSLTR2', 'ADORA3', 'GPR171', 'RHO', 'CCR1', 'GPR17', 'OR2H2', 'GPR4', 'GPR3', 'SSTR1', 'GPR6', 'SSTR3', 'HCRTR2', 'TRHR', 'HCRTR1', 'MAS1', 'OPN1SW', 'OR7A5', 'ACKR4', 'OR7C1', 'GPR18']",1.0796522202266488e-06,0,0,28
4,Spinal Cord Injury WP2431,6.3677885097934174e-06,3.8677542948955628,46.27481150774003,"['C1QB', 'NGFR', 'EGR1', 'CXCL1', 'LILRB2', 'PDYN', 'AIF1', 'TNFSF13B', 'SELP', 'LGALS3', 'NR4A1', 'ZFP36', 'VCAN', 'FCGR2A', 'LEP', 'CDK2', 'CSPG4', 'LTB']",0.000682945317675344,0,0,18
5,Complement system WP2806,1.2200116118033109e-05,4.30467032967033,48.703320293989194,"['FCN1', 'CR1', 'CD93', 'CFH', 'CFI', 'ITGB2', 'ICAM2', 'F13A1', 'PLG', 'LRP2', 'SELE', 'SELP', 'FCGR3A', 'VSIG4', 'TLR2']",0.0010467699629272407,0,0,15
6,Regulation of toll-like receptor signaling pathway WP1449,2.3241288362899395e-05,3.466799689613125,36.9892972917401,"['CD86', 'CISH', 'SYK', 'PELI3', 'CD180', 'LY96', 'TNFAIP3', 'IRAK3', 'SMAD6', 'PIK3R5', 'TLR1', 'IRF7', 'TLR9', 'CCL3', 'TLR7', 'TLR6', 'TLR5', 'TLR2']",0.0016617521179473067,0,0,18
7,Nuclear Receptors Meta-Pathway WP2882,0.000101858898403352,2.3155478852197207,21.284335667171206,"['SERPINA1', 'SRXN1', 'AMIGO2', 'TNFAIP3', 'SLC5A2', 'CYP2C19', 'SLC2A5', 'CYP3A4', 'SLC5A3', 'CYP3A5', 'CYP3A7', 'PRRG4', 'ZIC2', 'SLCO2B1', 'ENC1', 'PDK4', 'HMOX1', 'JUNB', 'SRGN', 'EGR1', 'HGF', 'MYOF', 'SLC39A12', 'TGFBR2', 'CYP2A6', 'BHLHE40', 'ALOX5AP', 'HSPA1A', 'FKBP5']",0.006242495345005429,0,0,29
8,Apoptosis Modulation and Signaling WP1772,0.00011934799251139582,3.621152067644339,32.711557797393205,"['IL1R2', 'TNFRSF10C', 'TNFRSF11B', 'TNFRSF10A', 'TNFRSF1B', 'TNFRSF10D', 'CASP10', 'BAG3', 'CASP4', 'CASP1', 'TNFSF10', 'PMAIP1', 'CYCS', 'HSPA1A']",0.0064000360984236004,0,0,14
9,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.00013958363755949685,10.101509797622873,89.66955273991515,"['TLR1', 'TLR9', 'TLR7', 'TLR6', 'TLR5', 'TLR2']",0.006653486723669349,0,0,6
10,Peptide GPCRs WP24,0.00019659759252035254,4.64319526627219,39.626660930781505,"['CX3CR1', 'CCR1', 'OXTR', 'GNRHR', 'OPRL1', 'SSTR1', 'SSTR3', 'HCRTR2', 'TRHR', 'HCRTR1']",0.008434036719123125,0,0,10
11,Complement and Coagulation Cascades WP558,0.00027581366130221337,4.42152719075796,36.23788649445952,"['C1QB', 'C1QA', 'SERPINA1', 'CR1', 'VWF', 'CFH', 'CFI', 'PLG', 'TFPI', 'C1QC']",0.010756732790786322,0,0,10
12,Imatinib and Chronic Myeloid Leukemia WP3640,0.0003826983557700711,7.935386168601716,62.43770904675884,"['PDGFRA', 'CSF1R', 'LYL1', 'SPRED2', 'FLT1', 'ABCG2']",0.013681466218780042,0,0,6
13,Toll-like Receptor Signaling related to MyD88 WP3858,0.0006762422797994248,5.638689499589828,41.15656428355663,"['TLR1', 'IRF7', 'TLR9', 'TLR7', 'TLR6', 'TLR5', 'TLR2']",0.022315995233381018,0,0,7
14,Tamoxifen metabolism WP691,0.0011459497855488688,12.321190755973365,83.43320784843081,"['CYP2A6', 'CYP2C19', 'CYP3A4', 'CYP3A5']",0.035115175571461765,0,0,4
15,Oxidation by Cytochrome P450 WP43,0.0013995115603775779,4.236532298869961,27.84093117633069,"['CYP39A1', 'CYP26B1', 'CYP2A6', 'CYP3A4', 'CYP2C19', 'CYP3A5', 'CYP2C18', 'CYP3A7']",0.04002603062679873,0,0,8
16,Vitamin D Receptor Pathway WP2877,0.001851214384404597,2.460701937568337,15.482523571268,"['LRRC25', 'COL13A1', 'TNFAIP3', 'TNFRSF11B', 'CYP3A4', 'CYP3A5', 'IL1RL1', 'CASP5', 'CDK2', 'PNOC', 'SOSTDC1', 'S100A4', 'LGALS9', 'JUNB', 'S100A9', 'S100A8']",0.04963568568184826,0,0,16
17,Hematopoietic Stem Cell Differentiation WP2849,0.002531185508050682,3.8010474374110736,22.726719220781717,"['LYL1', 'LEF1', 'RHOH', 'FOSB', 'IKZF1', 'CD34', 'FLI1', 'RUNX1']",0.06387521076198485,0,0,8
18,Toll-like Receptor Signaling Pathway WP75,0.0028541139153723505,2.916452268111036,17.087475892292737,"['CD86', 'TLR1', 'IRF7', 'TLR9', 'CCL3', 'LY96', 'TLR7', 'TLR6', 'TLR5', 'PIK3R5', 'TLR2']",0.06802304831637435,0,0,11
19,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.003154645590543563,4.82746965739745,27.800814221744123,"['OAS2', 'IRF7', 'TLR9', 'TLR7', 'TLR6', 'TLR2']",0.07122857675490465,0,0,6
20,Pre-implantation embryo WP3527,0.003957657141643666,3.9274942824471126,21.72730313686591,"['EGR1', 'ZFP36', 'ARGFX', 'FOXD1', 'FOSB', 'AQP3', 'TBX3']",0.08489174568825664,0,0,7
21,Heart Development WP1591,0.004479650829821368,4.440706713780918,24.016275235280396,"['FOXC1', 'BHLHE40', 'SMYD1', 'NFATC1', 'TBX2', 'FGF10']",0.09151286695206508,0,0,6
22,Platelet-mediated interactions with vascular and circulating cells WP4462,0.006058968374975159,6.718512979382544,34.30617664775806,"['SELP', 'TLR7', 'SELE', 'TLR2']",0.1130129318636671,0,0,4
23,Selective expression of chemokine receptors during T-cell polarization WP4494,0.006058968374975159,6.718512979382544,34.30617664775806,"['CCR1', 'IL4R', 'CCL3', 'IL18R1']",0.1130129318636671,0,0,4
24,Pregnane X receptor pathway WP2876,0.006736181606565941,4.865325077399381,24.32790030559049,"['CYP2A6', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'CYP3A7']",0.12040924621736619,0,0,5
25,"COVID-19, thrombosis and anticoagulation WP4927",0.007687326749368879,36.88862837045721,179.5805633799176,"['F13A1', 'PLG']",0.13191452701916997,0,0,2
26,Fatty Acid Omega Oxidation WP206,0.009069471934313563,9.230046948356808,43.407445414492905,"['CYP2A6', 'ADH1B', 'CYP3A4']",0.13895726642216139,0,0,3
27,Irinotecan pathway WP229,0.009069471934313563,9.230046948356808,43.407445414492905,"['CYP3A4', 'CYP3A5', 'ABCG2']",0.13895726642216139,0,0,3
28,Tgif disruption of Shh signaling WP3674,0.009069471934313563,9.230046948356808,43.407445414492905,"['TGIF2', 'NODAL', 'GLI3']",0.13895726642216139,0,0,3
29,Differentiation Pathway WP2848,0.012382179544789236,3.4677561837455833,15.22864078583327,"['CSF1R', 'HGF', 'FST', 'DKK1', 'NODAL', 'FGF10']",0.17459825400550547,0,0,6
30,Selenium Micronutrient Network WP15,0.0124201717741443,2.604720744680851,11.430643441026445,"['SERPINA3', 'KYNU', 'RFK', 'ALOX5AP', 'DIO3', 'PLG', 'KMO', 'SEPHS2', 'XDH']",0.17459825400550547,0,0,9
31,Allograft Rejection WP2328,0.01261665704934888,2.794502238756098,12.219624314173524,"['CD86', 'C1QB', 'PDGFRA', 'C1QA', 'HLA-DRB5', 'HLA-DOA', 'HLA-E', 'C1QC']",0.17459825400550547,0,0,8
32,Kynurenine Pathway and links to Cellular Senescence WP5044,0.014606244756028557,4.925656090873482,20.81733047546858,"['IL1R2', 'KYNU', 'KMO', 'ACMSD']",0.18597385999060398,0,0,4
33,Gastric acid production WP2596,0.014849904709301009,18.44314185228605,77.64123460676106,"['GRP', 'VIP']",0.18597385999060398,0,0,2
34,Proximal tubule transport WP4917,0.015092807873315767,2.9435570325900513,12.343915175913894,"['SLC22A6', 'SLC3A1', 'ATP6V0A4', 'SLC5A2', 'SLC22A8', 'ABCG2', 'ATP6V1B1']",0.18597385999060398,0,0,7
35,Glucocorticoid Receptor Pathway WP2880,0.015172692540025965,2.6925405173339056,11.277054389697057,"['SRGN', 'PRRG4', 'ZIC2', 'ENC1', 'AMIGO2', 'ALOX5AP', 'BHLHE40', 'TNFAIP3']",0.18597385999060398,0,0,8
36,Glycolysis and Gluconeogenesis WP534,0.017711094026010107,3.169914184755174,12.786051911849315,"['LDHC', 'PGAM1', 'ALDOB', 'ENO2', 'SLC2A5', 'ALDOA']",0.21105720380995377,0,0,6
37,NRF2 pathway WP2884,0.018583252756650456,2.0987040891694084,8.364373590418165,"['EGR1', 'CYP2A6', 'SERPINA1', 'SRXN1', 'HGF', 'HMOX1', 'SLC39A12', 'SLC5A2', 'SLC2A5', 'SLC5A3', 'TGFBR2', 'HSPA1A']",0.2154652819622445,0,0,12
38,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.020023438793019394,3.5538461538461537,13.89856545697403,"['TYROBP', 'SYK', 'ITGB2', 'LY96', 'PLG']",0.22141003191625486,0,0,5
39,Differentiation of white and brown adipocyte WP2895,0.02079129955646272,4.345614156355844,16.831522575708448,"['PLAC8', 'LEP', 'PRDM16', 'EBF3']",0.22141003191625486,0,0,4
40,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.02079129955646272,4.345614156355844,16.831522575708448,"['CD86', 'IL4R', 'TLR7', 'TGFBR2']",0.22141003191625486,0,0,4
41,EDA signaling in hair follicle development WP3930,0.021160399320667714,6.152190923317684,23.720533750289402,"['SOSTDC1', 'LTB', 'DKK1']",0.22141003191625486,0,0,3
42,Inflammatory Response Pathway WP453,0.024401631908410507,4.103930016973496,15.238324163176943,"['CD86', 'IL4R', 'COL1A2', 'TNFRSF1B']",0.24924524020733588,0,0,4
43,Farnesoid X receptor pathway WP2879,0.02647466961889342,5.5366197183098596,20.10660472173872,"['SLCO2B1', 'CYP3A4', 'FKBP5']",0.2632834855036567,0,0,3
44,Lung fibrosis WP3624,0.02700343441063146,2.8440699465434447,10.272186863906493,"['SERPINA1', 'CYSLTR2', 'HGF', 'MMP2', 'CCL3', 'HMOX1']",0.2632834855036567,0,0,6
45,Constitutive Androstane Receptor Pathway WP2875,0.02836728377190983,3.887686313315604,13.849955493056834,"['CYP2A6', 'CYP2C19', 'CYP3A4', 'CYP3A5']",0.2704347719588737,0,0,4
46,FTO Obesity Variant Mechanism WP3407,0.03465008809440117,9.22039859320047,31.003175452594064,"['PRDM16', 'UCP1']",0.3100400417138394,0,0,2
47,Thyroxine (Thyroid Hormone) Production WP1981,0.03465008809440117,9.22039859320047,31.003175452594064,"['TRH', 'CGA']",0.3100400417138394,0,0,2
48,Cardiac Progenitor Differentiation WP2406,0.036027258176077874,2.979696394686907,9.902959751304028,"['PDGFRA', 'ACTC1', 'THY1', 'DKK1', 'NODAL']",0.3100400417138394,0,0,5
49,Tryptophan metabolism WP465,0.036027258176077874,2.979696394686907,9.902959751304028,"['KYNU', 'DHCR24', 'CYP3A4', 'CYP2C18', 'ACMSD']",0.3100400417138394,0,0,5
50,Metapathway biotransformation Phase I and II WP702,0.03613520299695098,1.8838289402255866,6.255230893730502,"['CYP39A1', 'CYP26B1', 'CYP2A6', 'GLYAT', 'CYP2C19', 'GAL3ST2', 'CYP3A4', 'CYP2C18', 'SULT4A1', 'CYP3A5', 'CHST3', 'CYP3A7']",0.3100400417138394,0,0,12
51,ID signaling pathway WP53,0.03902571693129734,4.613262910798122,14.96327713966146,"['CDK2', 'ELK1', 'PAX2']",0.3282751483044423,0,0,3
52,Apoptosis WP254,0.041463762977239804,2.1759844433641224,6.926017946101272,"['CASP10', 'CASP4', 'CASP1', 'TNFSF10', 'IRF7', 'PMAIP1', 'CYCS', 'TNFRSF1B']",0.3420760445622284,0,0,8
53,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.04243978005423264,3.3569063134280523,10.60671331046205,"['EGR2', 'RAB3A', 'RAB25', 'NEFL']",0.3435219932691661,0,0,4
54,Oxidative Damage WP3941,0.044132734273286775,2.798752228163993,8.733656055933558,"['C1QB', 'C1QA', 'CYCS', 'TNFRSF1B', 'C1QC']",0.3506100556155561,0,0,5
55,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.046876579678434144,7.375849941383353,22.571849601114643,"['CD86', 'VIP']",0.3656373214917863,0,0,2
56,Pathways Regulating Hippo Signaling WP4540,0.05011282449038779,1.982016210739615,5.933122568225368,"['CDH5', 'PDGFRA', 'CSF1R', 'NGFR', 'PRKCH', 'FLT1', 'CDH20', 'LEF1', 'TEAD2']",0.38023433229788167,0,0,9
57,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.0505967269173502,1.7775373665480427,5.303937560457647,"['ADCYAP1', 'EGR1', 'SST', 'CDCA7L', 'BHLHE40', 'SSTR1', 'TAC1', 'ALDOA', 'RUNX3', 'YWHAG', 'HES5', 'YWHAH']",0.38023433229788167,0,0,12
58,"GPCRs, Other WP117",0.05270353718290024,2.193096418292293,6.454442211326794,"['GPR17', 'ADORA3', 'GPR55', 'GNRHR', 'ADRA1D', 'OR10A2', 'GPR18']",0.38023433229788167,0,0,7
59,Oxidative Stress WP408,0.05364776496018548,3.0767724245985115,9.000529972626179,"['HMOX1', 'CYBB', 'XDH', 'JUNB']",0.38023433229788167,0,0,4
60,Blood Clotting Cascade WP272,0.054065954009722104,3.953722334004024,11.53518499601149,"['F8A1', 'VWF', 'PLG']",0.38023433229788167,0,0,3
61,Cancer immunotherapy by PD-1 blockade WP4585,0.054065954009722104,3.953722334004024,11.53518499601149,"['CD8B', 'NFATC1', 'BATF']",0.38023433229788167,0,0,3
62,White fat cell differentiation WP4149,0.05979525121550516,2.9535135135135135,8.319542612127876,"['EGR2', 'MECOM', 'EBF1', 'KLF15']",0.40491604071186965,0,0,4
63,Hippo-Merlin Signaling Dysregulation WP4541,0.060302002300837314,1.8317417540570624,5.144245169995036,"['CDH5', 'PDGFRA', 'CSF1R', 'NGFR', 'FLT1', 'CDH20', 'ITGB4', 'ITGB2', 'TEAD2', 'CD44']",0.40491604071186965,0,0,10
64,NAD Biosynthesis II (from tryptophan) WP2485,0.06040705502461459,6.146150840171942,17.25009041925959,"['KYNU', 'KMO']",0.40491604071186965,0,0,2
65,Complement Activation WP545,0.06247683956078262,3.689906103286385,10.231959659043351,"['C1QB', 'C1QA', 'C1QC']",0.41234714110116527,0,0,3
66,Regulatory circuits of the STAT3 signaling pathway WP4538,0.06412920316889993,2.086579427875837,5.731532033977661,"['PDGFRA', 'SOCS3', 'DUSP2', 'CSF3R', 'PTPRC', 'IL21R', 'OSMR']",0.4168398205978496,0,0,7
67,Sleep regulation WP3591,0.06629970016128292,2.8397360571273613,7.705822300648,"['OXTR', 'CRH', 'HCRTR2', 'HCRTR1']",0.42451599058493095,0,0,4
68,GDNF/RET signaling axis WP4830,0.07145258537740543,3.4590669014084505,9.127513133253977,"['FOXC1', 'PAX2', 'GLI3']",0.45078175186627834,0,0,3
69,Macrophage markers WP4146,0.07507495499144409,5.267794339306649,13.639732707351026,"['CD86', 'CD163']",0.4632178084336963,0,0,2
70,PI3K-Akt signaling pathway WP4172,0.07558332538545161,1.4421529443112178,3.7243882215313846,"['NGFR', 'PDGFRA', 'CSF1R', 'CSF3R', 'IL4R', 'FLT1', 'SYK', 'VWF', 'ITGB4', 'HGF', 'OSMR', 'GNG11', 'PIK3R6', 'PIK3R5', 'COL1A2', 'CDK2', 'COL9A1', 'COL6A6', 'PIK3AP1', 'TLR2', 'FGF10']",0.4632178084336963,0,0,21
71,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.08043226887889683,2.3079411764705884,5.816796070285983,"['PDGFRA', 'MMP2', 'TNFSF10', 'ELK1', 'JUNB']",0.4859921598457288,0,0,5
72,Oncostatin M Signaling Pathway WP2374,0.08233057336202781,2.0909393959597304,5.221102338512955,"['SOCS3', 'EGR1', 'PRKCH', 'CDK2', 'OSMR', 'JUNB']",0.4905529996154157,0,0,6
73,IL-18 signaling pathway WP4754,0.08385077288124994,1.4853086864502183,3.6816592576128624,"['SLC12A3', 'NRN1', 'MMP2', 'TNFAIP3', 'TNFRSF11B', 'FUT1', 'SOCS3', 'NR4A1', 'ARL4D', 'COL1A2', 'CCL3', 'HMOX1', 'CYCS', 'LTB', 'IL18R1', 'TGM2', 'MYH7']",0.4927668707678935,0,0,17
74,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.09072739123471876,4.609026963657679,11.06118523236463,"['SOCS3', 'CHI3L1']",0.5205087329302834,0,0,2
75,IL1 and megakaryocytes in obesity WP2865,0.09099803023256703,3.0743348982785603,7.368926867972556,"['TLR1', 'S100A9', 'TLR2']",0.5205087329302834,0,0,3
76,Amyotrophic lateral sclerosis (ALS) WP2447,0.09575652858626356,2.460477869173521,5.772149370660537,"['CASP1', 'NEFL', 'NEFM', 'NEFH']",0.5405204047829877,0,0,4
77,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.09902575571992132,1.9785461887935387,4.575141344583518,"['FZD2', 'NEFL', 'NEFM', 'ELK1', 'NEFH', 'PFN2']",0.5476092156255175,0,0,6
78,TGF-beta Receptor Signaling WP560,0.09969348601690715,2.146511627906977,4.949115138623832,"['FST', 'LEF1', 'SMAD6', 'RUNX3', 'TGFBR2']",0.5476092156255175,0,0,5
79,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.10151325866844631,2.9123424759080803,6.662175225629158,"['SRXN1', 'HMOX1', 'ABCG2']",0.5476092156255175,0,0,3
80,Genes controlling nephrogenesis WP4823,0.10393841789707375,2.3809559910541678,5.390381246512543,"['FOXC1', 'FOXD1', 'GLI3', 'PAX2']",0.5476092156255175,0,0,4
81,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.10393841789707375,2.3809559910541678,5.390381246512543,"['IFITM3', 'BST2', 'IFITM2', 'JUNB']",0.5476092156255175,0,0,4
82,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.10722418208052091,4.096652338152924,9.147142482927746,"['HSD11B2', 'HSD3B1']",0.5476092156255175,0,0,2
83,Osteoblast Signaling WP322,0.10722418208052091,4.096652338152924,9.147142482927746,"['PDGFRA', 'TNFRSF11B']",0.5476092156255175,0,0,2
84,Role of Osx and miRNAs in tooth development WP3971,0.10722418208052091,4.096652338152924,9.147142482927746,"['NOTCH3', 'DKK1']",0.5476092156255175,0,0,2
85,Circadian rhythm related genes WP3594,0.11867844564416777,1.4840913756194833,3.163099722017782,"['KLF10', 'EGR1', 'NGFR', 'MAGEL2', 'EGR3', 'OPRL1', 'CARTPT', 'HCRTR2', 'HCRTR1', 'PER2', 'LEP', 'BHLHE40', 'CRH']",0.5703072431187409,0,0,13
86,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.12121184197151101,2.2363707581098886,4.719224246644195,"['CASP5', 'CASP1', 'CARD6', 'NOD2']",0.5703072431187409,0,0,4
87,TLR4 Signaling and Tolerance WP3851,0.12388397569524955,2.6346411804158283,5.502210543064467,"['INPP5D', 'IRF7', 'IRAK3']",0.5703072431187409,0,0,3
88,ACE Inhibitor Pathway WP554,0.12443695134290787,3.686752637749121,7.683030671726313,"['MAS1', 'ATP6AP2']",0.5703072431187409,0,0,2
89,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.12443695134290787,3.686752637749121,7.683030671726313,"['SST', 'DKK1']",0.5703072431187409,0,0,2
90,Iron metabolism in placenta WP2007,0.12443695134290787,3.686752637749121,7.683030671726313,"['HEPHL1', 'HAMP']",0.5703072431187409,0,0,2
91,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.12443695134290787,3.686752637749121,7.683030671726313,"['HLA-DRB5', 'CD8B']",0.5703072431187409,0,0,2
92,Serotonin and anxiety-related events WP3944,0.12443695134290787,3.686752637749121,7.683030671726313,"['ARC', 'CRH']",0.5703072431187409,0,0,2
93,Transcriptional cascade regulating adipogenesis WP4211,0.12443695134290787,3.686752637749121,7.683030671726313,"['EGR2', 'KLF15']",0.5703072431187409,0,0,2
94,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.12859424452910845,1.9633291614518147,4.026971137588246,"['FST', 'LEF1', 'SMAD6', 'RUNX3', 'TGFBR2']",0.5703072431187409,0,0,5
95,Mesodermal commitment pathway WP2857,0.129201217907482,1.5528815076326388,3.1777922766496425,"['FOXC1', 'ZIC2', 'BHLHE40', 'LEF1', 'TBX6', 'SMAD6', 'DKK1', 'NODAL', 'TEAD2', 'TBX3']",0.5703072431187409,0,0,10
96,IL-2 signaling pathway WP49,0.13027997628353521,2.1704569019147026,4.423541970785523,"['SOCS3', 'SYK', 'CISH', 'NMI']",0.5703072431187409,0,0,4
97,Neural Crest Cell Migration during Development WP4564,0.13027997628353521,2.1704569019147026,4.423541970785523,"['NGFR', 'MMP2', 'PIK3R6', 'PIK3R5']",0.5703072431187409,0,0,4
98,Vitamin B12 metabolism WP1533,0.13027997628353521,2.1704569019147026,4.423541970785523,"['SERPINA3', 'TCN1', 'PLG', 'LRP2']",0.5703072431187409,0,0,4
99,Canonical and non-canonical Notch signaling WP3845,0.13567946430171868,2.5147247119078107,5.0230621618458065,"['NOTCH3', 'MAML2', 'LEF1']",0.5879443453074475,0,0,3
100,Hedgehog Signaling Pathway WP4249,0.13961916061869142,2.1083095517878125,4.150917524869089,"['EVC2', 'LRP2', 'GLI3', 'GLI2']",0.5989661990541862,0,0,4
101,Osteoclast Signaling WP12,0.14224828607591472,3.351380155600554,6.535798756905366,"['GPR68', 'TNFRSF11B']",0.604203116104628,0,0,2
102,Nicotine Metabolism WP1600,0.1467963091614766,9.210772833723654,17.672795542947682,['CYP2A6'],0.6149674767574771,0,0,1
103,Prader-Willi and Angelman Syndrome WP3998,0.15248215024535453,1.8451764705882352,3.4702376650238547,"['PCSK1', 'MAGEL2', 'CGA', 'TYR', 'GABRD']",0.6149674767574771,0,0,5
104,Ebola Virus Pathway on Host WP4217,0.1551196091695795,1.5249853601405428,2.8418998688312667,"['BST2', 'SOCS3', 'HLA-DRB5', 'SCIN', 'ICAM2', 'IRF7', 'HLA-DOA', 'MERTK', 'HLA-E']",0.6149674767574771,0,0,9
105,Hepatitis B infection WP4666,0.1589246205300224,1.477775147928994,2.7181091787159315,"['EGR2', 'EGR3', 'ATP6AP1', 'CASP10', 'IRF7', 'CYCS', 'NFATC1', 'ELK1', 'TGFBR2', 'TLR2']",0.6149674767574771,0,0,10
106,Development of ureteric collection system WP5053,0.15905820447537888,1.9940928002032585,3.6661098570513007,"['FOXC1', 'GLI3', 'PAX2', 'GLI2']",0.6149674767574771,0,0,4
107,IL-6 signaling pathway WP364,0.15905820447537888,1.9940928002032585,3.6661098570513007,"['SOCS3', 'HCK', 'VIP', 'JUNB']",0.6149674767574771,0,0,4
108,Neural Crest Cell Migration in Cancer WP4565,0.15905820447537888,1.9940928002032585,3.6661098570513007,"['NGFR', 'MMP2', 'PIK3R6', 'PIK3R5']",0.6149674767574771,0,0,4
109,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.16033861633573296,2.3048708920187795,4.218990909123204,"['HGF', 'PIK3R5', 'TGFBR2']",0.6149674767574771,0,0,3
110,Cells and molecules involved in local acute inflammatory response  WP4493,0.1605509496429777,3.0719030871434154,5.618952926953618,"['SELP', 'ITGB2']",0.6149674767574771,0,0,2
111,Hedgehog Signaling Pathway Netpath WP47,0.1605509496429777,3.0719030871434154,5.618952926953618,"['GLI3', 'GLI2']",0.6149674767574771,0,0,2
112,Nephrogenesis WP5052,0.1605509496429777,3.0719030871434154,5.618952926953618,"['FOXD1', 'PAX2']",0.6149674767574771,0,0,2
113,VEGFA-VEGFR2 Signaling Pathway WP3888,0.17308427227542664,1.240458632310696,2.1757355137152175,"['FLT1', 'ELK1', 'FUT1', 'APOLD1', 'CDH5', 'DNAJB9', 'IGFBP7', 'IER5', 'CLIC1', 'CGNL1', 'DUSP5', 'EGR1', 'EGR3', 'MMP2', 'TNFRSF10C', 'CYBB', 'NFATC1', 'DKK1', 'SELE', 'NR4A1', 'NR4A3', 'TXNIP', 'CYCS', 'ALDOA', 'DSC1', 'HSPA1A']",0.6414287081833254,0,0,26
114,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.17314152247324552,2.2125352112676056,3.88000345655827,"['GGT5', 'CYSLTR2', 'TRPA1']",0.6414287081833254,0,0,3
115,Ovarian infertility WP34,0.17314152247324552,2.2125352112676056,3.88000345655827,"['EGR1', 'GJA4', 'PGR']",0.6414287081833254,0,0,3
116,Cori Cycle WP1946,0.1792471466200109,2.8354224907566055,4.874062107986477,"['PGAM1', 'ALDOA']",0.6414287081833254,0,0,2
117,Leptin Insulin Overlap WP3935,0.1792471466200109,2.8354224907566055,4.874062107986477,"['SOCS3', 'LEP']",0.6414287081833254,0,0,2
118,Major receptors targeted by epinephrine and norepinephrine WP4589,0.1792471466200109,2.8354224907566055,4.874062107986477,"['ADCY10', 'ADRA1D']",0.6414287081833254,0,0,2
119,Tryptophan catabolism leading to NAD+ production WP4210,0.1792471466200109,2.8354224907566055,4.874062107986477,"['KYNU', 'KMO']",0.6414287081833254,0,0,2
120,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.17942061767365744,1.8915905872427612,3.249795019889183,"['ACTC1', 'ITGB4', 'ITGB2', 'TEAD2']",0.6414287081833254,0,0,4
121,Acute viral myocarditis WP4298,0.1813510704425353,1.6281438370401164,2.779763367246502,"['ITGB2', 'CASP1', 'CYCS', 'NOD2', 'TLR5', 'AIF1']",0.6429719770235341,0,0,6
122,Cell migration and invasion through p75NTR WP4561,0.18621994176996956,2.127302275189599,3.5756267209738337,"['NGFR', 'MMP2', 'PARD3']",0.6494988212952597,0,0,3
123,miRNAs involvement in the immune response in sepsis WP4329,0.18621994176996956,2.127302275189599,3.5756267209738337,"['CCL3', 'IRF7', 'TLR7']",0.6494988212952597,0,0,3
124,Endoderm differentiation WP2853,0.1899061917488192,1.4448658649398705,2.400247377950706,"['DUSP4', 'DUSP5', 'HHEX', 'DUSP2', 'ONECUT1', 'LEF1', 'DKK1', 'NODAL', 'GLI2']",0.6495552758076026,0,0,9
125,Notch Signaling WP268,0.18991310869634243,1.844183313748531,3.063536359952369,"['NOTCH3', 'DTX3L', 'MFNG', 'HES5']",0.6495552758076026,0,0,4
126,Aflatoxin B1 metabolism WP699,0.19077847261482037,6.140124902419984,10.171990967899392,['CYP3A4'],0.6495552758076026,0,0,1
127,Osteoblast differentiation WP4787,0.1933125362478478,1.4766469893742622,2.4267911253297294,"['NOTCH3', 'PRKCH', 'FZD2', 'PIK3R6', 'GLI3', 'PIK3R5', 'FGF10', 'GLI2']",0.6530006145695016,0,0,8
128,Dopaminergic Neurogenesis WP2855,0.19824783617715402,2.6327248367107687,4.260373618660477,"['SLC18A2', 'GLI2']",0.6534698808654803,0,0,2
129,Serotonin and anxiety WP3947,0.19824783617715402,2.6327248367107687,4.260373618660477,"['ARC', 'CRH']",0.6534698808654803,0,0,2
130,GABA receptor Signaling WP4159,0.19954441583537977,2.048382889932186,3.3014164588120876,"['SLC32A1', 'GAD1', 'GABRD']",0.6534698808654803,0,0,3
131,Type II interferon signaling (IFNG) WP619,0.19954441583537977,2.048382889932186,3.3014164588120876,"['SOCS3', 'CYBB', 'PSMB9']",0.6534698808654803,0,0,3
132,Myometrial relaxation and contraction pathways WP289,0.2091206775683969,1.3777267508610793,2.155927149048583,"['RGS4', 'RGS18', 'OXTR', 'PRKCH', 'ACTC1', 'CRH', 'GNG11', 'RXFP2', 'YWHAG', 'YWHAH']",0.6714053597746437,0,0,10
133,IL-3 signaling pathway WP286,0.21144949773784785,1.756141234402104,2.7286379683732433,"['CD86', 'HCK', 'SYK', 'INPP5D']",0.6714053597746437,0,0,4
134,Fluoropyrimidine Activity WP1601,0.2130860930942814,1.9751006036217305,3.0536220680964092,"['CDA', 'CYP2A6', 'ABCG2']",0.6714053597746437,0,0,3
135,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.2130860930942814,1.9751006036217305,3.0536220680964092,"['PDGFRA', 'LEF1', 'GLI2']",0.6714053597746437,0,0,3
136,Prion disease pathway WP3995,0.2130860930942814,1.9751006036217305,3.0536220680964092,"['EBF1', 'ELK1', 'BATF']",0.6714053597746437,0,0,3
137,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.21441150183945498,1.6178534571723426,2.4912649198433146,"['PRKCH', 'OAS2', 'NOD2', 'IFI44L', 'TLR2']",0.6714053597746437,0,0,5
138,Netrin-UNC5B signaling pathway WP4747,0.22246480068768734,1.7151914300549285,2.5779093739828056,"['CDH5', 'ITGB4', 'INPP5D', 'SELE']",0.6915753586595498,0,0,4
139,MED and Pseudoachondroplasia genes WP4789,0.23249589618115987,4.60480093676815,6.717864446362019,['COL9A1'],0.7007389576620453,0,0,1
140,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.23249589618115987,4.60480093676815,6.717864446362019,['MAS1'],0.7007389576620453,0,0,1
141,Steroid Biosynthesis WP496,0.23249589618115987,4.60480093676815,6.717864446362019,['HSD3B1'],0.7007389576620453,0,0,1
142,Apoptosis Modulation by HSP70 WP384,0.23684650084148384,2.303341148886284,3.317601354432643,"['CYCS', 'HSPA1A']",0.7007389576620453,0,0,2
143,BMP Signaling Pathway in Eyelid Development WP3927,0.23684650084148384,2.303341148886284,3.317601354432643,"['FOXC1', 'FGF10']",0.7007389576620453,0,0,2
144,TP53 network WP1742,0.23684650084148384,2.303341148886284,3.317601354432643,"['TNFSF10', 'PMAIP1']",0.7007389576620453,0,0,2
145,Transcription co-factors SKI and SKIL protein partners WP4533,0.23684650084148384,2.303341148886284,3.317601354432643,"['MERTK', 'TEAD2']",0.7007389576620453,0,0,2
146,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.24491843590937665,1.6387517952735344,2.3054452512716828,"['IRF7', 'CCL3', 'CXCL1', 'TLR7']",0.7196575959254972,0,0,4
147,Corticotropin-releasing hormone signaling pathway WP2355,0.2473726921113787,1.4560163660033476,2.0338498629252277,"['NR4A1', 'HSD3B1', 'CRH', 'FOSB', 'ELK1', 'JUNB']",0.7219243871821868,0,0,6
148,Chemokine signaling pathway WP3929,0.2543791748224883,1.3284255319148937,1.818520647908344,"['CCR1', 'FGR', 'CX3CR1', 'HCK', 'PARD3', 'CCL3', 'PRKX', 'GNG11', 'PIK3R5']",0.7282448529010292,0,0,9
149,Pathways in clear cell renal cell carcinoma WP4018,0.25608169512729523,1.4370152815382498,1.9575866610188057,"['LDHC', 'PDGFRA', 'FLT1', 'ALDOB', 'ENO2', 'ALDOA']",0.7282448529010292,0,0,6
150,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.25630461020367573,2.1677125715467898,2.9510993092387126,"['EGR1', 'ELK1']",0.7282448529010292,0,0,2
151,IL-4 signaling pathway WP395,0.25632860789756506,1.6030245746691871,2.1821893913453403,"['SOCS3', 'IL4R', 'INPP5D', 'ELK1']",0.7282448529010292,0,0,4
152,22q11.2 copy number variation syndrome WP4657,0.264780692842728,1.373444399839422,1.8251062189634781,"['SLC7A4', 'CLDN5', 'CYP26B1', 'FOXC1', 'ACTC1', 'VWF', 'FGF10']",0.747308665983752,0,0,7
153,Effects of nitric oxide WP1995,0.27206506507787603,3.683606557377049,4.795002342068328,['XDH'],0.7530058897961859,0,0,1
154,Hfe effect on hepcidin production WP3924,0.27206506507787603,3.683606557377049,4.795002342068328,['HAMP'],0.7530058897961859,0,0,1
155,let-7 inhibition of ES cell reprogramming WP3299,0.27206506507787603,3.683606557377049,4.795002342068328,['EGR1'],0.7530058897961859,0,0,1
156,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.27578640186512404,2.0471538361339063,2.6369974441694453,"['H2AFZ', 'DUSP6']",0.7584126051290911,0,0,2
157,Phosphodiesterases in neuronal function WP4222,0.27944653590356633,1.5360360360360361,1.958360372557776,"['ADCY10', 'PDE10A', 'PDE6C', 'PDE5A']",0.7635832095708914,0,0,4
158,Nuclear receptors WP170,0.2830967905107018,1.675309432351686,2.114184253227477,"['NR4A1', 'NR0B1', 'PGR']",0.7686615387917156,0,0,3
159,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.29112730125141983,1.504592436269455,1.8566590109549874,"['LEF1', 'TNFRSF11B', 'JUNB', 'HES5']",0.7803013311672252,0,0,4
160,Globo Sphingolipid Metabolism WP1424,0.2952378088687091,1.9392854939223791,2.3658781054091627,"['A4GALT', 'FUT1']",0.7803013311672252,0,0,2
161,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.3095964806978627,3.0694769711163152,3.598917255294844,['CASP1'],0.7803013311672252,0,0,1
162,Benzo(a)pyrene metabolism WP696,0.3095964806978627,3.0694769711163152,3.598917255294844,['CYP3A4'],0.7803013311672252,0,0,1
163,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.3095964806978627,3.0694769711163152,3.598917255294844,['DHCR24'],0.7803013311672252,0,0,1
164,Codeine and Morphine Metabolism WP1604,0.3095964806978627,3.0694769711163152,3.598917255294844,['CYP3A4'],0.7803013311672252,0,0,1
165,COVID-19 adverse outcome pathway WP4891,0.3095964806978627,3.0694769711163152,3.598917255294844,['CCL3'],0.7803013311672252,0,0,1
166,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.3095964806978627,3.0694769711163152,3.598917255294844,['ALDH1L1'],0.7803013311672252,0,0,1
167,LDLRAD4 and what we know about it WP4904,0.3095964806978627,3.0694769711163152,3.598917255294844,['TGFBR2'],0.7803013311672252,0,0,1
168,Molybdenum cofactor (Moco) biosynthesis WP4507,0.3095964806978627,3.0694769711163152,3.598917255294844,['XDH'],0.7803013311672252,0,0,1
169,Nanomaterial-induced inflammasome activation WP3890,0.3095964806978627,3.0694769711163152,3.598917255294844,['CASP1'],0.7803013311672252,0,0,1
170,SARS-CoV-2 and COVID-19 Pathway WP4846,0.3095964806978627,3.0694769711163152,3.598917255294844,['TLR7'],0.7803013311672252,0,0,1
171,Eicosanoid Synthesis WP167,0.31461026237330303,1.8422039859320047,2.1303627649329857,"['ALOX5AP', 'TBXAS1']",0.7803013311672252,0,0,2
172,"GPCRs, Class B Secretin-like WP334",0.31461026237330303,1.8422039859320047,2.1303627649329857,"['ADGRE1', 'GIPR']",0.7803013311672252,0,0,2
173,Cytosolic DNA-sensing pathway WP4655,0.3146669703774591,1.4454044837676552,1.6712351109741685,"['CASP10', 'CASP1', 'IRF7', 'POLR2K']",0.7803013311672252,0,0,4
174,B Cell Receptor Signaling Pathway WP23,0.3281858197820853,1.3011016420702557,1.4496553218640855,"['PTPRC', 'SYK', 'INPP5D', 'HCLS1', 'PIK3AP1', 'ELK1']",0.808824995218757,0,0,6
175,Calcium Regulation in the Cardiac Cell WP536,0.33204438951622284,1.2201188986232792,1.3451647552228392,"['RGS4', 'GJD2', 'RGS18', 'PRKCH', 'GJA4', 'ADRA1D', 'GNG11', 'YWHAG', 'YWHAH']",0.808824995218757,0,0,9
176,Zinc homeostasis WP3529,0.3338602695339091,1.7543683358454754,1.924599481791253,"['SLC30A2', 'SLC39A12']",0.808824995218757,0,0,2
177,Nephrotic syndrome WP4758,0.3403814298349895,1.4938142367719833,1.6098663310741341,"['ITGB4', 'EMP2', 'PAX2']",0.808824995218757,0,0,3
178,Vitamin A and carotenoid metabolism WP716,0.3403814298349895,1.4938142367719833,1.6098663310741341,"['CYP26B1', 'RBP2', 'NPC1L1']",0.808824995218757,0,0,3
179,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.34490920987333185,1.1394333206013778,1.2128972087446377,"['NGFR', 'PDGFRA', 'CSF1R', 'CSF3R', 'IL4R', 'FLT1', 'VWF', 'ITGB4', 'HGF', 'ITGB2', 'HIF3A', 'OSMR', 'GNG11', 'PIK3R5', 'COL1A2', 'FGF10']",0.808824995218757,0,0,16
180,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.34519496726353116,2.630812980930077,2.7982534383847564,['TLR2'],0.808824995218757,0,0,1
181,Disorders of Folate Metabolism and Transport WP4259,0.34519496726353116,2.630812980930077,2.7982534383847564,['ALDH1L1'],0.808824995218757,0,0,1
182,Dual hijack model of Vif in HIV infection WP3300,0.34519496726353116,2.630812980930077,2.7982534383847564,['RUNX1'],0.808824995218757,0,0,1
183,Liver X receptor pathway WP2874,0.34519496726353116,2.630812980930077,2.7982534383847564,['CYP3A4'],0.808824995218757,0,0,1
184,Angiogenesis WP1539,0.35294902025250485,1.6745177448577213,1.7438957797000936,"['PDGFRA', 'FLT1']",0.808824995218757,0,0,2
185,Unfolded protein response WP4925,0.35294902025250485,1.6745177448577213,1.7438957797000936,"['PMAIP1', 'TXNIP']",0.808824995218757,0,0,2
186,Senescence and Autophagy in Cancer WP615,0.35594698484428317,1.2565049791198202,1.2979363186524593,"['IFI16', 'IRF7', 'CCL3', 'IGFBP7', 'CXCL1', 'CD44']",0.808824995218757,0,0,6
187,Adipogenesis WP236,0.35603756861946145,1.2286949685534592,1.2688966685560998,"['SOCS3', 'EGR2', 'CYP26B1', 'LEP', 'EBF1', 'UCP1', 'KLF15']",0.808824995218757,0,0,7
188,Hepatitis C and Hepatocellular Carcinoma WP3646,0.3689706830975782,1.4170278078728782,1.4128306957764005,"['MYOF', 'LEF1', 'CD44']",0.808824995218757,0,0,3
189,Metabolic reprogramming in colon cancer WP4290,0.3689706830975782,1.4170278078728782,1.4128306957764005,"['PGAM1', 'SLC1A5', 'ALDOB']",0.808824995218757,0,0,3
190,EPO Receptor Signaling WP581,0.37184202105089287,1.6016106835210766,1.5844513301681142,"['PTPRC', 'CISH']",0.808824995218757,0,0,2
191,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.37184202105089287,1.6016106835210766,1.5844513301681142,"['LEF1', 'DKK1']",0.808824995218757,0,0,2
192,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.37895996279480215,2.301814988290398,2.23350798065268,['CYP2C18'],0.808824995218757,0,0,1
193,Estrogen metabolism WP697,0.37895996279480215,2.301814988290398,2.23350798065268,['CYP3A4'],0.808824995218757,0,0,1
194,Estrogen Receptor Pathway WP2881,0.37895996279480215,2.301814988290398,2.23350798065268,['PDK4'],0.808824995218757,0,0,1
195,FOXP3 in COVID-19 WP5063,0.37895996279480215,2.301814988290398,2.23350798065268,['CD86'],0.808824995218757,0,0,1
196,Leptin and adiponectin WP3934,0.37895996279480215,2.301814988290398,2.23350798065268,['LEP'],0.808824995218757,0,0,1
197,Nucleotide GPCRs WP80,0.37895996279480215,2.301814988290398,2.23350798065268,['ADORA3'],0.808824995218757,0,0,1
198,PTF1A related regulatory pathway WP4147,0.37895996279480215,2.301814988290398,2.23350798065268,['FGF10'],0.808824995218757,0,0,1
199,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.37895996279480215,2.301814988290398,2.23350798065268,['TBX6'],0.808824995218757,0,0,1
200,Vitamin B12 Disorders WP4271,0.37895996279480215,2.301814988290398,2.23350798065268,['TCN1'],0.808824995218757,0,0,1
201,Vitamin D Metabolism WP1531,0.37895996279480215,2.301814988290398,2.23350798065268,['GC'],0.808824995218757,0,0,1
202,Prostaglandin Synthesis and Regulation WP98,0.3831869344778831,1.3815140845070422,1.3251929732381182,"['HSD11B2', 'ANXA3', 'TBXAS1']",0.8137979945099597,0,0,3
203,Cannabinoid receptor signaling WP3869,0.3905087541327821,1.534779210629152,1.443160400201549,"['CYP2C19', 'CYP3A4']",0.8172110025510415,0,0,2
204,Gastric Cancer Network 2 WP2363,0.3905087541327821,1.534779210629152,1.443160400201549,"['PLAC8', 'COL9A1']",0.8172110025510415,0,0,2
205,Purinergic signaling WP4900,0.3905087541327821,1.534779210629152,1.443160400201549,"['GNAT3', 'ADORA3']",0.8172110025510415,0,0,2
206,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.40892235977447855,1.4732942555685815,1.3174638784908161,"['CXCL1', 'GLI2']",0.8277601236921841,0,0,2
207,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.40892235977447855,1.4732942555685815,1.3174638784908161,"['MMP2', 'SELE']",0.8277601236921841,0,0,2
208,Autosomal recessive Osteopetrosis pathways WP4788,0.4109857956793362,2.045927660681759,1.8192319718422085,['TCIRG1'],0.8277601236921841,0,0,1
209,Dopamine metabolism WP2436,0.4109857956793362,2.045927660681759,1.8192319718422085,['TYR'],0.8277601236921841,0,0,1
210,Gene regulatory network modelling somitogenesis  WP2854,0.4109857956793362,2.045927660681759,1.8192319718422085,['TBX6'],0.8277601236921841,0,0,1
211,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.4109857956793362,2.045927660681759,1.8192319718422085,['HMOX1'],0.8277601236921841,0,0,1
212,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.4109857956793362,2.045927660681759,1.8192319718422085,['ELK1'],0.8277601236921841,0,0,1
213,Valproic acid pathway WP3871,0.4109857956793362,2.045927660681759,1.8192319718422085,['CYP2A6'],0.8277601236921841,0,0,1
214,Folate Metabolism WP176,0.42533012822299554,1.2848837209302326,1.098433780728201,"['SERPINA3', 'RFK', 'PLG']",0.8526477804096498,0,0,3
215,MAPK Signaling Pathway WP382,0.437198962720915,1.0788127795253686,0.8925739799336763,"['DUSP4', 'DUSP2', 'IL1R2', 'NFATC1', 'ELK1', 'DUSP6', 'TGFBR2', 'NR4A1', 'CACNG1', 'HSPA1B', 'HSPA1A', 'FGF10', 'CACNG5']",0.8636280339208489,0,0,13
216,Alanine and aspartate metabolism WP106,0.44136194681466423,1.8412177985948477,1.5059136236038597,['GAD1'],0.8636280339208489,0,0,1
217,Biogenic Amine Synthesis WP550,0.44136194681466423,1.8412177985948477,1.5059136236038597,['GAD1'],0.8636280339208489,0,0,1
218,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.44136194681466423,1.8412177985948477,1.5059136236038597,['IKZF1'],0.8636280339208489,0,0,1
219,Breast cancer pathway WP4262,0.44219481317066134,1.107917373125849,0.9040658282517328,"['NOTCH3', 'HEYL', 'FRAT2', 'FZD2', 'LEF1', 'PGR', 'HES5', 'FGF10']",0.8636280339208489,0,0,8
220,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.44446586993459614,1.1881278192638642,0.9634314742518066,"['CR1', 'ITGB4', 'DKK1', 'PAX2']",0.8636280339208489,0,0,4
221,SARS-CoV-2 mitochondrial interactions WP5038,0.4448992902016494,1.3639876687942338,1.104703619964383,"['IRF7', 'TLR7']",0.8636280339208489,0,0,2
222,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.4472384790415973,1.151029411764706,0.9261911438301003,"['NHSL1', 'PRDM16', 'UCP1', 'DIO3', 'TRH']",0.8642581419317353,0,0,5
223,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.4624246312718633,1.3151900854128287,1.0143688860568356,"['COL1A2', 'TNFRSF11B']",0.87317898264906,0,0,2
224,Synaptic Vesicle Pathway WP2267,0.466425924064344,1.2008573178199633,0.915841113227231,"['RAB3A', 'SLC32A1', 'SLC18A2']",0.87317898264906,0,0,3
225,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.47017329834949384,1.6737279114328294,1.2630853500399875,['SMAD6'],0.87317898264906,0,0,1
226,Cancer immunotherapy by CTLA4 blockade WP4582,0.47017329834949384,1.6737279114328294,1.2630853500399875,['CD86'],0.87317898264906,0,0,1
227,Computational Model of Aerobic Glycolysis WP4629,0.47017329834949384,1.6737279114328294,1.2630853500399875,['ALDOA'],0.87317898264906,0,0,1
228,LTF danger signal response pathway WP4478,0.47017329834949384,1.6737279114328294,1.2630853500399875,['TLR2'],0.87317898264906,0,0,1
229,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.47017329834949384,1.6737279114328294,1.2630853500399875,['PGR'],0.87317898264906,0,0,1
230,Purine metabolism WP4792,0.47017329834949384,1.6737279114328294,1.2630853500399875,['XDH'],0.87317898264906,0,0,1
231,Sulfation Biotransformation Reaction WP692,0.47017329834949384,1.6737279114328294,1.2630853500399875,['SULT4A1'],0.87317898264906,0,0,1
232,TNF-alpha signaling pathway WP231,0.4775483303687148,1.1092133238837705,0.8198083743351207,"['RFK', 'TNFAIP3', 'CYBA', 'TNFRSF1B', 'SELE']",0.8793040389873609,0,0,5
233,Aryl Hydrocarbon Receptor Pathway WP2873,0.4796203849021969,1.2697578526094515,0.9329677277105041,"['MYOF', 'JUNB']",0.8793040389873609,0,0,2
234,Tumor suppressor activity of SMARCB1 WP4204,0.4796203849021969,1.2697578526094515,0.9329677277105041,"['GLI3', 'GLI2']",0.8793040389873609,0,0,2
235,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.49010773751001807,1.1158352027917244,0.7957356023276574,"['ITGB4', 'LEF1', 'CACNG1', 'CACNG5']",0.8930027558074372,0,0,4
236,Pathogenic Escherichia coli infection WP2272,0.49308599608531267,1.150674882629108,0.8136096291847342,"['HCLS1', 'LY96', 'TLR5']",0.8930027558074372,0,0,3
237,Melatonin metabolism and effects WP3298,0.4964739470955436,1.2273544353262993,0.8594233635007841,"['PER2', 'CYP2C19']",0.8930027558074372,0,0,2
238,Cysteine and methionine catabolism WP4504,0.4975003697854953,1.534153005464481,1.071082696072661,['SQOR'],0.8930027558074372,0,0,1
239,Ganglio Sphingolipid Metabolism WP1423,0.4975003697854953,1.534153005464481,1.071082696072661,['FUT1'],0.8930027558074372,0,0,1
240,RANKL/RANK signaling pathway WP2018,0.5061659566450728,1.1271198620293188,0.7674454159578102,"['SYK', 'TNFRSF11B', 'NFATC1']",0.8981879343386584,0,0,3
241,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5123440497012758,1.0828782746941314,0.7241844919853775,"['LEF1', 'PMAIP1', 'CYCS', 'TGFBR2']",0.8981879343386584,0,0,4
242,Disruption of postsynaptic signaling by CNV WP4875,0.5129748846055645,1.1876867223839958,0.7928146090542147,"['ARC', 'YWHAG']",0.8981879343386584,0,0,2
243,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5129748846055645,1.1876867223839958,0.7928146090542147,"['OAS2', 'TLR7']",0.8981879343386584,0,0,2
244,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.5129748846055645,1.1876867223839958,0.7928146090542147,"['FYB1', 'TEAD2']",0.8981879343386584,0,0,2
245,The influence of laminopathies on Wnt signaling WP4844,0.5129748846055645,1.1876867223839958,0.7928146090542147,"['LEF1', 'HES5']",0.8981879343386584,0,0,2
246,Ras signaling WP4223,0.5158072981806483,1.0290075327078103,0.681225662263712,"['PDGFRA', 'CSF1R', 'NGFR', 'FLT1', 'PLA2G12B', 'RASAL3', 'ELK1', 'GNG11', 'PLA1A']",0.8981879343386584,0,0,9
247,Cytokines and Inflammatory Response WP530,0.5234195421553953,1.4160511619528013,0.9167118057532089,['CXCL1'],0.8981879343386584,0,0,1
248,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.5234195421553953,1.4160511619528013,0.9167118057532089,['PMAIP1'],0.8981879343386584,0,0,1
249,Phytochemical activity on NRF2 transcriptional activation WP3,0.5234195421553953,1.4160511619528013,0.9167118057532089,['HMOX1'],0.8981879343386584,0,0,1
250,Riboflavin and CoQ disorders WP5037,0.5234195421553953,1.4160511619528013,0.9167118057532089,['RFK'],0.8981879343386584,0,0,1
251,Parkinson's disease pathway WP2371,0.5291147454333662,1.1504982415005862,0.7323496102555173,"['PINK1', 'CYCS']",0.898587754233058,0,0,2
252,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5291147454333662,1.1504982415005862,0.7323496102555173,"['HGF', 'ELK1']",0.898587754233058,0,0,2
253,Modulators of TCR signaling and T cell activation WP5072,0.5317857070712269,1.0827809997238331,0.6837920933519439,"['CD5', 'TNFAIP3', 'RHOH']",0.898587754233058,0,0,3
254,Leptin signaling pathway WP2034,0.534125588180489,1.0518045996306866,0.6596122062564403,"['SOCS3', 'CISH', 'LEP', 'ELK1']",0.898587754233058,0,0,4
255,Prolactin Signaling Pathway WP2037,0.534125588180489,1.0518045996306866,0.6596122062564403,"['SOCS3', 'CISH', 'ELK1', 'YWHAG']",0.898587754233058,0,0,4
256,Drug Induction of Bile Acid Pathway WP2289,0.5480032701870257,1.3148210103713616,0.79083068468063,['CYP3A4'],0.9076965363329499,0,0,1
257,ERK Pathway in Huntington's Disease WP3853,0.5480032701870257,1.3148210103713616,0.79083068468063,['ELK1'],0.9076965363329499,0,0,1
258,Galanin receptor pathway WP4970,0.5480032701870257,1.3148210103713616,0.79083068468063,['UCP1'],0.9076965363329499,0,0,1
259,Overview of nanoparticle effects WP3287,0.5480032701870257,1.3148210103713616,0.79083068468063,['HMOX1'],0.9076965363329499,0,0,1
260,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.5554113074108066,1.022457239848544,0.6012522430946359,"['FRAT2', 'FZD2', 'LEF1', 'DKK1']",0.9092283916735189,0,0,4
261,Oxysterols derived from cholesterol WP4545,0.5602862899027554,1.0826839528308392,0.6272068191515733,"['CYP39A1', 'CYP3A4']",0.9092283916735189,0,0,2
262,Notch Signaling Pathway Netpath WP61,0.5687673806260429,1.0224308815858112,0.5769411318149013,"['NOTCH3', 'MAML2', 'HES5']",0.9092283916735189,0,0,3
263,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.5713202838378737,1.227088212334114,0.686930496093347,['SYTL4'],0.9092283916735189,0,0,1
264,Glutathione metabolism WP100,0.5713202838378737,1.227088212334114,0.686930496093347,['GGT5'],0.9092283916735189,0,0,1
265,Hypertrophy Model WP516,0.5713202838378737,1.227088212334114,0.686930496093347,['NR4A3'],0.9092283916735189,0,0,1
266,Mammalian disorder of sexual development WP4842,0.5713202838378737,1.227088212334114,0.686930496093347,['FST'],0.9092283916735189,0,0,1
267,MAPK pathway in congenital thyroid cancer WP4928,0.5713202838378737,1.227088212334114,0.686930496093347,['ELK1'],0.9092283916735189,0,0,1
268,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.5713202838378737,1.227088212334114,0.686930496093347,['LEF1'],0.9092283916735189,0,0,1
269,Type II diabetes mellitus WP1584,0.5713202838378737,1.227088212334114,0.686930496093347,['PIK3R5'],0.9092283916735189,0,0,1
270,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.5753094534074078,1.0516831351532407,0.5814200798302102,"['NGFR', 'GABRD']",0.9092283916735189,0,0,2
271,Neovascularisation processes WP4331,0.5753094534074078,1.0516831351532407,0.5814200798302102,"['ACVRL1', 'NOTCH3']",0.9092283916735189,0,0,2
272,Endochondral Ossification with Skeletal Dysplasias WP4808,0.5806873312193188,1.0037772087067862,0.5455958979217372,"['SCIN', 'RUNX3', 'GLI3']",0.9092283916735189,0,0,3
273,Endochondral Ossification WP474,0.5806873312193188,1.0037772087067862,0.5455958979217372,"['SCIN', 'RUNX3', 'GLI3']",0.9092283916735189,0,0,3
274,Ferroptosis WP4313,0.5899542084829588,1.0224045851243975,0.5395334894682882,"['HMOX1', 'CYBB']",0.9092283916735189,0,0,2
275,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5899542084829588,1.0224045851243975,0.5395334894682882,"['PRKCH', 'HSD3B1']",0.9092283916735189,0,0,2
276,Kit receptor signaling pathway WP304,0.5923967043342271,0.9857897384305835,0.5161385687183834,"['INPP5D', 'JUNB', 'TBX2']",0.9092283916735189,0,0,3
277,Proteasome Degradation WP183,0.5923967043342271,0.9857897384305835,0.5161385687183834,"['H2AFZ', 'HLA-E', 'PSMB9']",0.9092283916735189,0,0,3
278,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.5934357801132524,1.1503220140515222,0.6002682529732961,['LEF1'],0.9092283916735189,0,0,1
279,Canonical and non-canonical TGF-B signaling WP3874,0.5934357801132524,1.1503220140515222,0.6002682529732961,['TGFBR2'],0.9092283916735189,0,0,1
280,miR-509-3p alteration of YAP1/ECM axis WP3967,0.5934357801132524,1.1503220140515222,0.6002682529732961,['TEAD2'],0.9092283916735189,0,0,1
281,IL-5 signaling pathway WP127,0.6042196118510749,0.9947086594214378,0.5011516810986617,"['SYK', 'ELK1']",0.9224562757441678,0,0,2
282,Nanomaterial induced apoptosis WP2507,0.6144116038697984,1.0825871332139414,0.5273175949484029,['CYCS'],0.9239282136523598,0,0,1
283,Nicotine Activity on Dopaminergic Neurons WP1602,0.6144116038697984,1.0825871332139414,0.5273175949484029,['SLC18A2'],0.9239282136523598,0,0,1
284,Proteoglycan biosynthesis WP4784,0.6144116038697984,1.0825871332139414,0.5273175949484029,['CHST3'],0.9239282136523598,0,0,1
285,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.6144116038697984,1.0825871332139414,0.5273175949484029,['IGFBP7'],0.9239282136523598,0,0,1
286,Fas ligand pathway and stress induction of heat shock proteins WP314,0.618105821254609,0.9684704140186339,0.4659268591558274,"['CASP10', 'CYCS']",0.9239282136523598,0,0,2
287,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.618105821254609,0.9684704140186339,0.4659268591558274,"['HCK', 'CISH']",0.9239282136523598,0,0,2
288,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.6343064201935645,1.0223783502472028,0.465410271309242,['ELK1'],0.9309383774450191,0,0,1
289,Transcription factor regulation in adipogenesis WP3599,0.6343064201935645,1.0223783502472028,0.465410271309242,['LEP'],0.9309383774450191,0,0,1
290,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.6349740014630296,0.9197414806110459,0.41772011355789884,"['FRAT2', 'FZD2', 'LEF1', 'DKK1']",0.9309383774450191,0,0,4
291,ESC Pluripotency Pathways WP3931,0.6352397002756537,0.9196470588235294,0.41729249285088743,"['PDGFRA', 'FZD2', 'SMAD6', 'ELK1', 'FGF10']",0.9309383774450191,0,0,5
292,AGE/RAGE pathway WP2324,0.6370709521827055,0.9198356807511737,0.41473021781655056,"['LGALS3', 'MMP2', 'CYCS']",0.9309383774450191,0,0,3
293,Focal Adhesion WP306,0.6376608766989799,0.9244621419232141,0.4159605187854624,"['FGR', 'HCK', 'PDGFRA', 'COL1A2', 'FLT1', 'VWF', 'ITGB4', 'HGF', 'ELK1']",0.9309383774450191,0,0,9
294,Wnt signaling WP428,0.6435633185592815,0.9104834012813046,0.4012817740747447,"['FRAT2', 'FZD2', 'LEF1', 'NFATC1', 'DKK1']",0.9309383774450191,0,0,5
295,Neural Crest Differentiation WP2064,0.644244884202069,0.908328618473546,0.3993706299049015,"['NOTCH3', 'MIA', 'TBX6', 'HES5']",0.9309383774450191,0,0,4
296,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6447461386583904,0.9199296600234467,0.4037558611662901,"['NEFL', 'CYCS']",0.9309383774450191,0,0,2
297,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6476888297889096,0.904698683906719,0.3929512584021261,"['EGR1', 'CDK2', 'CGA']",0.9309383774450191,0,0,3
298,One-carbon metabolism WP241,0.6531758778810041,0.9685073339085418,0.41249584258850747,['ALDH1L1'],0.9309383774450191,0,0,1
299,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.6531758778810041,0.9685073339085418,0.41249584258850747,['CD86'],0.9309383774450191,0,0,1
300,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.6531758778810041,0.9685073339085418,0.41249584258850747,['FCGR2A'],0.9309383774450191,0,0,1
301,Vitamin D in inflammatory diseases WP4482,0.6531758778810041,0.9685073339085418,0.41249584258850747,['NFATC1'],0.9309383774450191,0,0,1
302,TGF-beta Signaling Pathway WP366,0.6592259630740976,0.896951937717257,0.37374993012125896,"['KLF10', 'COL1A2', 'ITGB4', 'FOSB', 'JUNB', 'TGFBR2']",0.9333251225636604,0,0,6
303,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.6682564092380555,0.8758663089649005,0.3530471110193965,"['CASP1', 'HSPA1B', 'HSPA1A']",0.9333251225636604,0,0,3
304,Regulation of Microtubule Cytoskeleton WP2038,0.6698944438040335,0.876011834980182,0.35096111150811976,"['RHO', 'PHLDB2']",0.9333251225636604,0,0,2
305,Matrix Metalloproteinases WP129,0.6710727640079893,0.9200234192037471,0.366976831603893,['MMP2'],0.9333251225636604,0,0,1
306,miRNA targets in ECM and membrane receptors WP2911,0.6710727640079893,0.9200234192037471,0.366976831603893,['COL1A2'],0.9333251225636604,0,0,1
307,Purine metabolism and related disorders WP4224,0.6710727640079893,0.9200234192037471,0.366976831603893,['XDH'],0.9333251225636604,0,0,1
308,Urea cycle and metabolism of amino groups WP497,0.6710727640079893,0.9200234192037471,0.366976831603893,['CKM'],0.9333251225636604,0,0,1
309,DNA damage response WP707,0.6782056610796904,0.8621258802816901,0.33476753312641516,"['CDK2', 'PMAIP1', 'CYCS']",0.9333251225636604,0,0,3
310,MECP2 and Associated Rett Syndrome WP3584,0.6782056610796904,0.8621258802816901,0.33476753312641516,"['SST', 'GAD1', 'FKBP5']",0.9333251225636604,0,0,3
311,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.6880471513254369,0.8761570201851232,0.32759327823560713,['LEF1'],0.9333251225636604,0,0,1
312,Hippo-Yap signaling pathway WP4537,0.6880471513254369,0.8761570201851232,0.32759327823560713,['TEAD2'],0.9333251225636604,0,0,1
313,NAD+ biosynthetic pathways WP3645,0.6880471513254369,0.8761570201851232,0.32759327823560713,['ACMSD'],0.9333251225636604,0,0,1
314,NRF2-ARE regulation WP4357,0.6880471513254369,0.8761570201851232,0.32759327823560713,['HMOX1'],0.9333251225636604,0,0,1
315,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6880471513254369,0.8761570201851232,0.32759327823560713,['ITGB4'],0.9333251225636604,0,0,1
316,Statin inhibition of cholesterol production WP430,0.6880471513254369,0.8761570201851232,0.32759327823560713,['APOC1'],0.9333251225636604,0,0,1
317,16p11.2 proximal deletion syndrome WP4949,0.6974366727356094,0.8358941527955612,0.30120907579235806,"['SPN', 'TBX6', 'ALDOA']",0.9333251225636604,0,0,3
318,miRNA regulation of DNA damage response WP1530,0.6974366727356094,0.8358941527955612,0.30120907579235806,"['CDK2', 'PMAIP1', 'CYCS']",0.9333251225636604,0,0,3
319,Estrogen signaling pathway WP712,0.7041465372960771,0.8362784756227379,0.2933403931083095,['ELK1'],0.9333251225636604,0,0,1
320,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7041465372960771,0.8362784756227379,0.2933403931083095,['CGA'],0.9333251225636604,0,0,1
321,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.7041465372960771,0.8362784756227379,0.2933403931083095,['TGFBR2'],0.9333251225636604,0,0,1
322,RAS and bradykinin pathways in COVID-19 WP4969,0.7041465372960771,0.8362784756227379,0.2933403931083095,['CYP3A4'],0.9333251225636604,0,0,1
323,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7041465372960771,0.8362784756227379,0.2933403931083095,['PLA1A'],0.9333251225636604,0,0,1
324,Exercise-induced Circadian Regulation WP410,0.7048889037543729,0.8174547349224958,0.28587624141031504,"['PER2', 'CLDN5']",0.9333251225636604,0,0,2
325,Gastric Cancer Network 1 WP2361,0.7194159765903013,0.7998676305875165,0.26340884049677266,['GATD3A'],0.940943457186705,0,0,1
326,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7194159765903013,0.7998676305875165,0.26340884049677266,['PMAIP1'],0.940943457186705,0,0,1
327,MTHFR deficiency WP4288,0.7194159765903013,0.7998676305875165,0.26340884049677266,['CYCS'],0.940943457186705,0,0,1
328,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7194159765903013,0.7998676305875165,0.26340884049677266,['CD8B'],0.940943457186705,0,0,1
329,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.72646011370381,0.7825696540370657,0.25008711429395825,"['IRF7', 'ELK1']",0.9472686589025364,0,0,2
330,Photodynamic therapy-induced unfolded protein response WP3613,0.7338982064732866,0.7664910226385636,0.23714078155134952,['DNAJB9'],0.9535885632092145,0,0,1
331,Wnt signaling pathway and pluripotency WP399,0.7357524811707459,0.7991621110713738,0.24523209978841135,"['PRKCH', 'FZD2', 'LEF1', 'CD44']",0.9535885632092145,0,0,4
332,Oxidative phosphorylation WP623,0.746680978881092,0.7505323348565687,0.21924344532736786,"['ATP6AP1', 'ATP6AP2']",0.9574175693361413,0,0,2
333,7-oxo-C and 7beta-HC pathways WP5064,0.7476337662648189,0.7357845433255269,0.21399707625859507,['HSD11B2'],0.9574175693361413,0,0,1
334,Ethanol effects on histone modifications WP3996,0.7476337662648189,0.7357845433255269,0.21399707625859507,['ADH1B'],0.9574175693361413,0,0,1
335,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.7476337662648189,0.7357845433255269,0.21399707625859507,['CYP3A4'],0.9574175693361413,0,0,1
336,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.7523743824488646,0.8045704263495912,0.22891736725970657,"['NGFR', 'EGR1', 'EGR2', 'RAB3A', 'ELK1', 'CDK5R1']",0.9606208633052467,0,0,6
337,Interferon type I signaling pathways WP585,0.7563015669026005,0.7354747948417351,0.20542920433789172,"['SOCS3', 'PTPRC']",0.962606536966116,0,0,2
338,Monoamine Transport WP727,0.7606611096305672,0.7074401008827238,0.193532508543515,['TNFRSF11B'],0.962606536966116,0,0,1
339,Striated Muscle Contraction Pathway WP383,0.7606611096305672,0.7074401008827238,0.193532508543515,['ACTC1'],0.962606536966116,0,0,1
340,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.7656048205810255,0.721007746592189,0.19257334069278823,"['CASP10', 'IRF7']",0.9660131412625292,0,0,2
341,IL17 signaling pathway WP2112,0.7730167120610044,0.6811952467690172,0.1753768571942087,['IL17RB'],0.9668343133357752,0,0,1
342,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.7730167120610044,0.6811952467690172,0.1753768571942087,['PGR'],0.9668343133357752,0,0,1
343,Signal transduction through IL1R WP4496,0.7730167120610044,0.6811952467690172,0.1753768571942087,['IRAK3'],0.9668343133357752,0,0,1
344,Genotoxicity pathway WP4286,0.7832878775934176,0.6937114291402154,0.16944247874243884,"['PCDH8', 'HIST1H2BC']",0.9729808933745921,0,0,2
345,PDGFR-beta pathway WP3972,0.784735172745009,0.656825025092004,0.1592202828463818,['ELK1'],0.9729808933745921,0,0,1
346,Sphingolipid pathway WP1422,0.784735172745009,0.656825025092004,0.1592202828463818,['SERINC1'],0.9729808933745921,0,0,1
347,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.7958493104949479,0.6341355083582331,0.1448019386646745,['TBXAS1'],0.9752347175731243,0,0,1
348,Endothelin Pathways WP2197,0.7958493104949479,0.6341355083582331,0.1448019386646745,['ADCY10'],0.9752347175731243,0,0,1
349,Monoamine GPCRs WP58,0.7958493104949479,0.6341355083582331,0.1448019386646745,['ADRA1D'],0.9752347175731243,0,0,1
350,Ectoderm Differentiation WP2858,0.8009172114208395,0.7405123339658444,0.1643920303588189,"['STC1', 'TNFRSF11B', 'NFATC1', 'EDA2R', 'GLI3']",0.9752347175731243,0,0,5
351,Glioblastoma signaling pathways WP2261,0.8015558421454927,0.6977625245141736,0.15434551511547848,"['PDGFRA', 'PRKCH', 'CDK2']",0.9752347175731243,0,0,3
352,DNA damage response (only ATM dependent) WP710,0.8024658631778855,0.7203520656206078,0.15852497100458798,"['MLKL', 'LEF1', 'PMAIP1', 'PIK3R5']",0.9752347175731243,0,0,4
353,Male infertility WP4673,0.8024658631778855,0.7203520656206078,0.15852497100458798,"['CYP26B1', 'MMP2', 'EPSTI1', 'ETV5']",0.9752347175731243,0,0,4
354,Gastrin signaling pathway WP4659,0.8083182261500306,0.7133127217551025,0.15179255754401047,"['EGR1', 'PRKCH', 'ELK1', 'CD44']",0.9795720876224948,0,0,4
355,Alpha 6 Beta 4 signaling pathway WP244,0.816387537062888,0.5931479942585178,0.12032962855510398,['ITGB4'],0.9810371243696889,0,0,1
356,BDNF-TrkB Signaling WP3676,0.816387537062888,0.5931479942585178,0.12032962855510398,['ARC'],0.9810371243696889,0,0,1
357,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.816387537062888,0.5931479942585178,0.12032962855510398,['NFATC1'],0.9810371243696889,0,0,1
358,CAMKK2  Pathway WP4874,0.8258691633808359,0.5745755269320844,0.10992716688742007,['HMOX1'],0.9869021478840629,0,0,1
359,MAPK Cascade WP422,0.8258691633808359,0.5745755269320844,0.10992716688742007,['ELK1'],0.9869021478840629,0,0,1
360,p38 MAPK Signaling Pathway WP400,0.8348617025312169,0.5571286636860407,0.10055570321777137,['ELK1'],0.988564104231698,0,0,1
361,Wnt signaling in kidney disease WP4150,0.8348617025312169,0.5571286636860407,0.10055570321777137,['FZD2'],0.988564104231698,0,0,1
362,p53 transcriptional gene network WP4963,0.8362510888887702,0.612504884720594,0.10953202234356513,"['PMAIP1', 'TNFRSF10D']",0.988564104231698,0,0,2
363,Endometrial cancer WP4155,0.8427815715525008,0.6024253838909922,0.1030433335814341,"['LEF1', 'ELK1']",0.988564104231698,0,0,2
364,Pathways affected in adenoid cystic carcinoma WP3651,0.8427815715525008,0.6024253838909922,0.1030433335814341,"['UHRF1', 'INSRR']",0.988564104231698,0,0,2
365,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.8433903546592109,0.5407080865132938,0.09209630705696287,['TNFSF9'],0.988564104231698,0,0,1
366,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.8433903546592109,0.5407080865132938,0.09209630705696287,['PMAIP1'],0.988564104231698,0,0,1
367,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.8514790231128737,0.5252258280361325,0.08444602628505961,['HSD3B1'],0.9905599952252385,0,0,1
368,Bladder cancer WP2828,0.859150380959651,0.5106036950299245,0.07751541439081877,['MMP2'],0.9905599952252385,0,0,1
369,Phosphoinositides metabolism WP4971,0.859150380959651,0.5106036950299245,0.07751541439081877,['INPP5D'],0.9905599952252385,0,0,1
370,Vitamin D-sensitive calcium signaling in depression WP4698,0.859150380959651,0.5106036950299245,0.07751541439081877,['CALB1'],0.9905599952252385,0,0,1
371,Cell cycle WP179,0.8637676089215516,0.6440307584472345,0.09431928189959553,"['CDK2', 'CDC14A', 'YWHAG', 'YWHAH']",0.9905599952252385,0,0,4
372,Small cell lung cancer WP4658,0.8644951999231555,0.6120500782472613,0.08912032196882184,"['CDK2', 'CKS2', 'CYCS']",0.9905599952252385,0,0,3
373,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8666018485447803,0.5652087654432321,0.0809241247919322,"['MMP2', 'TIE1']",0.9905599952252385,0,0,2
374,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8700008314441068,0.6599661447312738,0.09190761896735669,"['CLDN5', 'NOTCH3', 'FZD2', 'MMP2', 'TGFBR2']",0.9905599952252385,0,0,5
375,PDGF Pathway WP2526,0.8733260813332684,0.4836681868605941,0.06551105412363703,['ELK1'],0.9905599952252385,0,0,1
376,Integrin-mediated Cell Adhesion WP185,0.8782931113820176,0.5921929426018476,0.0768517806271431,"['ITGB4', 'ITGB2', 'RHO']",0.9905599952252385,0,0,3
377,ATM Signaling Pathway WP2516,0.8798701715085978,0.47123641385936466,0.06030926731886779,['CDK2'],0.9905599952252385,0,0,1
378,Copper homeostasis WP3286,0.8798701715085978,0.47123641385936466,0.06030926731886779,['XAF1'],0.9905599952252385,0,0,1
379,Head and Neck Squamous Cell Carcinoma WP4674,0.8822422860850453,0.5401696434728639,0.06767707674429556,"['TGFBR2', 'PIK3R5']",0.9905599952252385,0,0,2
380,Integrated breast cancer pathway WP1984,0.884583167050796,0.6413410119292472,0.0786532552879804,"['CDK2', 'RHO', 'SMAD6', 'TFPI', 'TGFBR2']",0.9905599952252385,0,0,5
381,Aryl Hydrocarbon Receptor Netpath WP2586,0.886076557167379,0.4594262295081967,0.055568486611864885,['CDK2'],0.9905599952252385,0,0,1
382,DNA Replication WP466,0.886076557167379,0.4594262295081967,0.055568486611864885,['CDK2'],0.9905599952252385,0,0,1
383,Eukaryotic Transcription Initiation WP405,0.8919626459915729,0.4481921517107443,0.05124226764042604,['POLR2K'],0.9905599952252385,0,0,1
384,ATM Signaling Network in Development and Disease  WP3878,0.8975449492403013,0.4374930299988848,0.04728953035332756,['CDK5R1'],0.9905599952252385,0,0,1
385,Integrated Cancer Pathway WP1971,0.8975449492403013,0.4374930299988848,0.04728953035332756,['CDK2'],0.9905599952252385,0,0,1
386,Interleukin-11 Signaling Pathway WP2332,0.8975449492403013,0.4374930299988848,0.04728953035332756,['SOCS3'],0.9905599952252385,0,0,1
387,Ciliopathies WP4803,0.8989663328985452,0.643192197218606,0.06850620456742736,"['EVC2', 'DNAH11', 'ZIC2', 'CCDC65', 'GLI3', 'GLI2']",0.9905599952252385,0,0,6
388,Thermogenesis WP4321,0.9021953796807156,0.5560890596101864,0.057235007792913586,"['ADCY10', 'PRDM16', 'UCP1']",0.9905599952252385,0,0,3
389,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9028391281995337,0.4272915418550188,0.04367385050837447,['DHCR24'],0.9905599952252385,0,0,1
390,One-carbon metabolism and related pathways WP3940,0.9028391281995337,0.4272915418550188,0.04367385050837447,['GAD1'],0.9905599952252385,0,0,1
391,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9078600374575011,0.41755375771769215,0.040362857385938845,['ADCY10'],0.9905599952252385,0,0,1
392,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9078600374575011,0.41755375771769215,0.040362857385938845,['EIF4A2'],0.9905599952252385,0,0,1
393,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9123653723090135,0.4895349745994529,0.044897573702378346,"['FZD2', 'CISH']",0.9905599952252385,0,0,2
394,T-cell receptor (TCR) signaling pathway WP69,0.9123653723090135,0.4895349745994529,0.044897573702378346,"['FYB1', 'NFATC1']",0.9905599952252385,0,0,2
395,Histone Modifications WP2369,0.9126217666637633,0.4082487639864689,0.037327719306190284,['SMYD1'],0.9905599952252385,0,0,1
396,Alzheimer's disease WP2059,0.9160268710521737,0.4830628740667613,0.04236924157021423,"['CYCS', 'CDK5R1']",0.9905599952252385,0,0,2
397,Rett syndrome causing genes WP4312,0.921420452594715,0.3908266480641786,0.031984795385265934,['GABRD'],0.9905599952252385,0,0,1
398,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.921420452594715,0.3908266480641786,0.031984795385265934,['ARC'],0.9905599952252385,0,0,1
399,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9254821078874003,0.382660031225605,0.029633376315059398,['PTPRC'],0.9905599952252385,0,0,1
400,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.9292824981208737,0.45879249706916764,0.033648987797214286,"['PDGFRA', 'HGF']",0.9905599952252385,0,0,2
401,Wnt Signaling Pathway WP363,0.9293340491200479,0.37482674568656504,0.027469937289779776,['LEF1'],0.9905599952252385,0,0,1
402,Pyrimidine metabolism WP4022,0.9322732597255288,0.45309944567467036,0.03177555154999425,"['CDA', 'POLR2K']",0.9905599952252385,0,0,2
403,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.9329870922439123,0.36730679156908663,0.02547783630169214,['SOCS3'],0.9905599952252385,0,0,1
404,Translation Factors WP107,0.9329870922439123,0.36730679156908663,0.02547783630169214,['EIF4A2'],0.9905599952252385,0,0,1
405,Retinoblastoma gene in cancer WP2446,0.9351440514364139,0.447545249192234,0.03001001056502145,"['H2AFZ', 'CDK2']",0.9905599952252385,0,0,2
406,Pancreatic adenocarcinoma pathway WP4263,0.9378992766235331,0.44212488876961537,0.02834582775740366,"['DUSP6', 'TGFBR2']",0.9910315016539304,0,0,2
407,Fragile X Syndrome  WP4549,0.9445008616002286,0.4824561403508772,0.02754760868125432,"['ARC', 'GAD1', 'GABRD']",0.992057459292366,0,0,3
408,IL-1 signaling pathway WP195,0.9458076942903909,0.3400121432908318,0.018944121195057048,['IRAK3'],0.992057459292366,0,0,1
409,PPAR signaling pathway WP3942,0.9458076942903909,0.3400121432908318,0.018944121195057048,['UCP1'],0.992057459292366,0,0,1
410,G Protein Signaling Pathways WP35,0.9500867243671992,0.41687093680059684,0.021344629769114273,"['PRKCH', 'GNG11']",0.9929288216612068,0,0,2
411,MET in type 1 papillary renal cell carcinoma WP4205,0.9512674725005967,0.3278270324523252,0.0163782392092256,['HGF'],0.9929288216612068,0,0,1
412,3q29 copy number variation syndrome WP4906,0.9605937476969157,0.30589383294301326,0.012298063438872294,['HAMP'],0.9957459363804174,0,0,1
413,AMP-activated protein kinase (AMPK) signaling WP1403,0.962632135078381,0.30085998387530233,0.01145793328679288,['LEP'],0.9957459363804174,0,0,1
414,G1 to S cell cycle control WP45,0.962632135078381,0.30085998387530233,0.01145793328679288,['CDK2'],0.9957459363804174,0,0,1
415,Insulin Signaling WP481,0.9643108937699101,0.4786679262382587,0.017395525976126418,"['SOCS3', 'EGR1', 'PRKCH', 'ELK1']",0.9957459363804174,0,0,4
416,Melanoma WP4685,0.9681367808104169,0.28670228337236536,0.00928396443991908,['ELK1'],0.9957459363804174,0,0,1
417,Nonalcoholic fatty liver disease WP4396,0.9768290564640271,0.40384217067108535,0.009467518368240094,"['SOCS3', 'LEP', 'CYCS']",0.9957459363804174,0,0,3
418,Non-small cell lung cancer WP4255,0.9768347767359278,0.26202743392438943,0.006141334563877366,['CYCS'],0.9957459363804174,0,0,1
419,Regulation of Actin Cytoskeleton WP51,0.9777535842608411,0.4008687159453069,0.00901858383455095,"['PDGFRA', 'PIK3R5', 'FGF10']",0.9957459363804174,0,0,3
420,DNA IR-damage and cellular response via ATR WP4016,0.984858806858289,0.2350327268360055,0.003585892286357536,['CDK2'],0.9957459363804174,0,0,1
421,Amino Acid metabolism WP3925,0.9856427931442927,0.23204280674710223,0.003355633396053073,['PDK4'],0.9957459363804174,0,0,1
422,Ciliary landscape WP4352,0.985921397707453,0.44340376927470015,0.006286865038205393,"['DOCK5', 'CDH23', 'NEFL', 'COPS7A', 'NEFM']",0.9957459363804174,0,0,5
423,EGF/EGFR signaling pathway WP437,0.9889937071198363,0.35622827876349006,0.003942488881405275,"['INPP5D', 'FOSB', 'ELK1']",0.9957459363804174,0,0,3
424,Androgen receptor signaling pathway WP138,0.9889947105078017,0.21816103490576558,0.0024142345219369597,['ETV5'],0.9957459363804174,0,0,1
425,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.989256052739562,0.30004035900294046,0.0032410600277089606,"['TRIP10', 'CYP3A4']",0.9957459363804174,0,0,2
426,ErbB signaling pathway WP673,0.990617756277006,0.21059786266117528,0.0019852079587825504,['ELK1'],0.9957459363804174,0,0,1
427,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9911037641828397,0.20819139876516926,0.0018604074147994562,['UCP1'],0.9957459363804174,0,0,1
428,7q11.23 copy number variation syndrome WP4932,0.9944886479174346,0.18876602525411043,0.001043233487917239,['CLDN5'],0.9957762113964967,0,0,1
429,Genes related to primary cilium development (based on CRISPR) WP4536,0.9957762113964967,0.1794553887128622,0.0007595869246490568,['EVC2'],0.9957762113964967,0,0,1
